エリトロイド原始細胞の表皮遺伝的再プログラム:がんの免疫療法強化のための洞察
Zi-Zhan Li1, Xuan-Yu Su1, Cheng-Ke Zhou1
1The State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430079, China.
International journal of biological sciences
|February 16, 2026
まとめ
腫瘍の微環境 (TME) の赤色素原始細胞 (EPC) は,表遺伝的に再プログラムされ,がんの免疫療法への耐性につながる. この再プログラミングをターゲットにすることで,治療の効果が向上する可能性があります.
科学分野:
- がん免疫学 がん免疫学
- エピジェネティクス エピジェネティクス
- 腫瘍マイクロ環境の研究
背景:
- 癌の免疫療法は改善された結果をもたらしますが,低い応答率のために制限に直面しています.
- 腫瘍の微環境 (TME) を理解することは,がん治療に対する耐性を克服する鍵です.
- TME内の赤色素原始細胞 (EPC) の再プログラミングは,免疫療法に対する耐性の新興メカニズムです.
研究 の 目的:
- TMEにおけるEPCの表遺伝的再プログラミングをレビューする.
- 再プログラムされたEPCと腫瘍/免疫細胞の相互作用を探求する.
- 強化免疫療法のためのEPCを標的としたエピジェネティック薬の評価.
主な方法:
- TME内のEPC再プログラムにおける表遺伝的メカニズムに焦点を当てた文献レビュー.
- 腫瘍および免疫細胞とのEPCクロストラックの分析.
- EPCの表遺伝子変調を含む治療戦略の評価.
主要な成果:
- EPCは,TMEで表遺伝的再プログラムを受け,免疫逃避に影響を与えます.
- 再プログラムされたEPCは免疫細胞と相互作用し,免疫療法に対する耐性を高めます.
- EPCにおける表遺伝的変異は,潜在的な治療目標である.
結論:
- EPCのエピジェネティック再プログラミングは,がんの免疫療法に対する抵抗性の重要な要因です.
- EPCのエピジェネティック変異をターゲットにすることで,免疫療法の有効性を改善する見込みがある.
- 病理的なEPC再プログラミングの逆転に関するさらなる研究は,がん治療の進歩に不可欠です.
関連する概念動画
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:14Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
01:32Chromatin Modification in iPS Cells
2.2K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.2K
02:38Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K